Reduced ACE-2 expression in the airways of asthma patients may limit viral entry into cells, and the Th2 immune response, prominent in allergic diseases like atopic asthma, could suppress the pro-inflammatory Th1 response via the type 2 cytokines IL-4 and IL-13, offering further protection. This evidence concerns the gene ACE2 and atopic asthma.